Operating Income Summary of Kingworld Medicines Group Limited

Kingworld Medicines Group Limited's latest annual operating income in 2023 was 96.8 Million CNY , up 34.02% from previous year.
Kingworld Medicines Group Limited's latest quarterly operating income in 2024 Q2 was 28.96 Million CNY , down 0.0% from previous quarter.
Kingworld Medicines Group Limited reported an annual operating income of 72.23 Million CNY in 2022, up 0.01% from previous year.
Kingworld Medicines Group Limited reported an annual operating income of 72.22 Million CNY in 2021, down -1.93% from previous year.
Kingworld Medicines Group Limited reported a quarterly operating income of 28.96 Million CNY for 2024 Q2, down 0.0% from previous quarter.
Kingworld Medicines Group Limited reported a quarterly operating income of 96.8 Million CNY for 2023 FY, up 34.02% from previous quarter.

Annual Operating Income Chart of Kingworld Medicines Group Limited (2023 - 2009)

Historical Annual Operating Income of Kingworld Medicines Group Limited (2023 - 2009)

Year	Operating Income	Operating Income Growth
2023	96.8 Million CNY	34.02%
2022	72.23 Million CNY	0.01%
2021	72.22 Million CNY	-1.93%
2020	73.64 Million CNY	-4.03%
2019	76.74 Million CNY	11.47%
2018	68.84 Million CNY	-28.06%
2017	95.7 Million CNY	-0.02%
2016	95.72 Million CNY	94.74%
2015	49.15 Million CNY	-0.3%
2014	49.3 Million CNY	-13.1%
2013	56.73 Million CNY	-13.88%
2012	65.87 Million CNY	-16.09%
2011	78.5 Million CNY	18.28%
2010	66.37 Million CNY	17.76%
2009	56.36 Million CNY	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	28.96 Million CNY	58.27%
2024 Q2	28.96 Million CNY	0.0%
2023 FY	96.8 Million CNY	34.02%
2023 Q4	18.3 Million CNY	76.23%
2023 Q1	28.95 Million CNY	35.74%
2023 Q3	10.38 Million CNY	-64.14%
2023 Q2	28.95 Million CNY	0.0%
2022 Q1	18.83 Million CNY	39.34%
2022 Q3	21.33 Million CNY	13.23%
2022 Q4	21.33 Million CNY	0.0%
2022 FY	72.23 Million CNY	0.01%
2022 Q2	18.83 Million CNY	0.0%
2021 FY	72.22 Million CNY	-1.93%
2021 Q1	22.1 Million CNY	294.91%
2021 Q4	13.51 Million CNY	0.0%
2021 Q3	13.51 Million CNY	-38.83%
2021 Q2	22.1 Million CNY	0.0%
2020 Q4	5.59 Million CNY	0.0%
2020 FY	73.64 Million CNY	-4.03%
2020 Q3	5.59 Million CNY	-79.53%
2020 Q2	27.34 Million CNY	0.0%
2020 Q1	27.34 Million CNY	318.88%
2019 Q4	6.52 Million CNY	0.0%
2019 FY	76.74 Million CNY	11.47%
2019 Q1	26.67 Million CNY	175.32%
2019 Q3	6.52 Million CNY	-75.53%
2019 Q2	26.67 Million CNY	0.0%
2018 FY	68.84 Million CNY	-28.06%
2018 Q3	9.68 Million CNY	-55.43%
2018 Q2	21.73 Million CNY	0.0%
2018 Q1	21.73 Million CNY	172.74%
2018 Q4	9.68 Million CNY	0.0%
2017 FY	95.7 Million CNY	-0.02%
2017 Q4	7.97 Million CNY	0.0%
2017 Q3	7.97 Million CNY	-65.88%
2017 Q2	23.36 Million CNY	0.0%
2017 Q1	23.36 Million CNY	-25.16%
2016 Q4	31.21 Million CNY	0.0%
2016 Q2	20 Million CNY	0.0%
2016 Q3	31.21 Million CNY	56.04%
2016 Q1	20 Million CNY	105.32%
2016 FY	95.72 Million CNY	94.74%
2015 Q2	16.84 Million CNY	0.0%
2015 Q3	9.74 Million CNY	-42.17%
2015 Q4	9.74 Million CNY	0.0%
2015 FY	49.15 Million CNY	-0.3%
2015 Q1	16.84 Million CNY	56.93%
2014 FY	49.3 Million CNY	-13.1%
2014 Q1	14.03 Million CNY	108.86%
2014 Q4	10.73 Million CNY	0.0%
2014 Q2	14.03 Million CNY	0.0%
2014 Q3	10.73 Million CNY	-23.48%
2013 Q1	7.75 Million CNY	-45.35%
2013 Q3	6.71 Million CNY	-13.4%
2013 Q4	6.71 Million CNY	0.0%
2013 FY	56.73 Million CNY	-13.88%
2013 Q2	7.75 Million CNY	0.0%
2012 FY	65.87 Million CNY	-16.09%
2012 Q1	16.46 Million CNY	0.0%
2012 Q2	16.46 Million CNY	0.0%
2012 Q4	14.19 Million CNY	0.0%
2012 Q3	14.19 Million CNY	-13.82%
2011 Q4	16.46 Million CNY	-16.09%
2011 Q2	19.62 Million CNY	0.0%
2011 Q1	19.62 Million CNY	0.0%
2011 FY	78.5 Million CNY	18.28%
2011 Q3	19.62 Million CNY	0.0%
2010 Q1	16.59 Million CNY	0.0%
2010 Q4	19.62 Million CNY	18.28%
2010 Q3	16.59 Million CNY	0.0%
2010 Q2	16.59 Million CNY	0.0%
2010 FY	66.37 Million CNY	17.76%
2009 FY	56.36 Million CNY	0.0%
2009 Q2	14.09 Million CNY	0.0%
2009 Q3	14.09 Million CNY	0.0%
2009 Q4	16.59 Million CNY	17.76%
2009 Q1	14.09 Million CNY	0.0%
2008 Q4	14.09 Million CNY	0.0%

Peer Operating Income Comparison of Kingworld Medicines Group Limited

Name	Operating Income	Operating Income Difference
China Healthwise Holdings Limited	-112.57 Million HKD	185.99%
Tycoon Group Holdings Limited	336.55 Million HKD	71.236%
Beijing Tong Ren Tang Chinese Medicine Company Limited	624.14 Million HKD	84.49%

Global Stocks Search

Kingworld Medicines Group Limited (1110.HK)

Operating Income Summary of Kingworld Medicines Group Limited

Annual Operating Income Chart of Kingworld Medicines Group Limited (2023 - 2009)

Historical Annual Operating Income of Kingworld Medicines Group Limited (2023 - 2009)

Peer Operating Income Comparison of Kingworld Medicines Group Limited